132
Participants
Start Date
January 9, 2018
Primary Completion Date
June 30, 2020
Study Completion Date
June 30, 2020
Echocardiography
Conventional transthoracic echocardiography will be performed, in addition 3D-imaging and acquisitions with high frame rate. The data from these patients will be anonymized and transferred for post-hoc analysis in dedicated computer software (GE Vingmed, EchoPac 2.0) and in validated machine learning algorithms.
MRI
Cardiac MRI will be performed. In all patients without contraindications a gadolinium-based contrast agent will be given.
Blood test
Conventional brachial venous blood samples will be drawn. Blood samples will be analyzed for markers of myocardial fibrosis at Oslo University Hospital.The findings will be related to imaging findings.
ECG and Holter-ECG
ECG/Holter-ECG will be performed, and the findings will be related to the imaging findings.
6 min walking test
6 MWT will be performed, and the findings will be related to findings from MRI/echocardiography.
Department of Circulation and Medical Imaging, Trondheim
St. Olavs Hospital
OTHER
Oslo University Hospital
OTHER
Norwegian University of Science and Technology
OTHER